WillItSurvive
Medical technology and health companies · subsidiary of Altaris, LLC · United States

Sharecare

sharecare.com ↗

Digital health navigation platform helping employers and health plans guide members to care.

Protection under test
Assessed 22 July 2026 · Evidence as of 22 July 2026
Something worth protecting exists and is being tested right now.
On the recordSince 22 July 2026 · Checkable from H1 2026 · Every call on the record Checkpoint: AskMD commercial launch and first adoption numbers after long pre-launch waitlist
The call

Sharecare has scale and contracts but a shrinking business and a flagship AI product still stuck on a waitlist while bigger rivals move faster.

Sharecare helps people navigate health benefits, find doctors, and understand symptoms through a digital platform. Larger competitors like UnitedHealthcare and Cigna can offer similar services for free bundled with insurance plans, and artificial intelligence systems like Amazon's Bedrock can now handle the same symptom-checking and guidance work that Sharecare does. The company's survival depends on whether its new AskMD product launches successfully and attracts enough users before its owner decides to sell it or shut it down.

Why
01
AI pressure: AWS Bedrock native health AI and generalist chatbots. Symptom checking and benefits navigation are simple chat tasks that Bedrock or ChatGPT-style tools can do without Sharecare's app. Could AI do the core job? Only partly.
02
Bigger players: UnitedHealthcare Advocacy, Cigna/Evernorth, Transcarent-Accolade. Big insurers bundle navigation for free with health plans, and better funded rivals are consolidating the same market Sharecare serves. Could a giant copy it? Yes, easily.
03
What protects it. Existing employer and health plan contracts covering millions of lives that would need to actively switch away.
What would change this call
AskMD moves from waitlist to commercial launch with published enterprise adoption numbers. Shows whether Sharecare's AI turnaround bet is materializing or slipping past H1 2026 target.
Sharecare or Altaris discloses updated revenue/financials after the Oct 2024 reporting blackout. Reveals whether the 13% revenue decline has continued, stabilized, or reversed.
Altaris announces a sale, merger, or further restructuring of Sharecare within the next year. Indicates whether Sharecare becomes a consolidation target rather than a surviving challenger.
Key numbers
  • Revenue down 13% y/y, $403.7M TTM (Oct 2024)
  • Employees fell 26% since 2023 per Revelio Labs (Jun 2026)
  • Altaris bought company for $1.43/share, $518M (Oct 2024)
Named risks
  • AskMD remains in pre-launch waitlist stage as of July 2026, delaying revenue-turnaround thesis. Severity: high
  • Payers like UnitedHealthcare and Cigna bundle free navigation, undercutting core enterprise product. Severity: high
  • Headcount fell roughly 26% from 2023 to Dec 2025 per Revelio Labs, signaling continued contraction. Severity: medium
  • Conflicting employee counts between Revelio Labs and Crustdata create uncertainty about true trajectory. Severity: low
  • No public financials since Oct 2024 take-private limits visibility into current revenue trend. Severity: medium
Rivals, as read in July 2026
RivalDirectionEvidence
Transcarent-Accoladegaining onMerged Apr 8 2025 into $621M entity with 20M+ members vs Sharecare's ~10M plan members
Personify HealthcontestingRebranded Feb 7 2024 from Virgin Pulse-HealthComp merger, positioned directly against Sharecare in navigation
UnitedHealthcare/Cigna Evernorthlosing toBundle navigation-like services free into insurance, undercutting independent vendors as of 2026
Quantum Healthgaining onAcquired Embold Health in early 2025 to expand navigation capabilities
Bamboo HealthcontestingLaunched Bamboo Bridge behavioral-health navigation module December 2025
Questions people ask
Is Sharecare profitable in 2024?
Sharecare's last public financials showed a net loss of $128.5M on revenue of $445.3M for FY2023 (reported March 28, 2024). Since Altaris took it private on October 22, 2024 at $1.43/share, no audited financials have been disclosed, so current profitability is unknown.
Who owns Sharecare now?
Altaris Capital (Altaris, LLC), a New York healthcare-focused PE firm managing roughly $10B, completed a take-private acquisition of Sharecare on October 22, 2024 for $1.43 per share, a deal reported around $518M. Founder Jeff Arnold rolled over equity and remains executive chairman.
Is Sharecare laying off employees?
Workforce data from Revelio Labs shows Sharecare's headcount fell from about 4,300 in 2023 to 3,175 by December 2025, a roughly 26% cumulative decline, with active job postings dropping 58% in 2025 to 670, though Crustdata reported a higher, growing figure of 3,846 in June 2026.
Could AI replace Sharecare's core product?
Sharecare is rebuilding its flagship AskMD navigation tool on Amazon Bedrock foundation models via an exclusive AWS cloud partnership announced June 30, 2026, targeting symptom-checking and benefits navigation. As of July 2026 AskMD is still in pre-launch waitlist stage, not yet proven against AI-native rivals.
Who is Sharecare's biggest competitor?
Transcarent and Accolade completed a $621M merger on April 8, 2025, creating a combined entity claiming 20M+ members across 1,700+ employer and health-plan clients, versus Sharecare's roughly 10M plan members, making it the largest scaled rival in digital health navigation.
Did Sharecare win its recent lawsuit?
Yes. In Kovacic v. Sharecare, a merger-fraud case tied to a 2020 doc.ai acquisition dispute, a jury returned a complete defense verdict for Sharecare on November 14, 2025, with final judgment entered December 24, 2025.
Timeline
  • 2026-06-30Sharecare announces exclusive AWS cloud partnership and Amazon Bedrock for AskMD
  • 2025-12-24Final judgment entered in Kovacic v. Sharecare merger-fraud case
  • 2025-12-08AskMD announced with CLEAR identity-verification partnership
  • 2025-11-14Jury returns complete defense verdict for Sharecare in Kovacic case
  • 2025-07-30Sharecare joins CMS Aligned Network as early adopter
  • 2025-06-12Sharecare launches AR/AI patient-education tools for life-sciences clients
  • 2025-04-08Transcarent and Accolade complete $621M merger, forming 20M+ member rival
  • 2024-10-22Altaris completes take-private acquisition of Sharecare at $1.43/share
  • 2024-07-01Sharecare launches Medicaid navigation platform covering ~750,000 members
  • 2024-03-28Sharecare reports FY2023 revenue $445.3M and net loss $128.5M
Revision history
22 July 2026
First assessed. Protection under test. The text above is fixed as of this date and is not edited afterwards.
In the same band
23andMeAngelalign TechnologyVolpara Health Technologies
More in Medical technology and health companies →
Sources